Artis Ventures (AV) is the famous VC, which was founded in 2005. The company was established in North America in United States. The main department of described VC is located in the San Francisco.
Among the most popular fund investment industries, there are Enterprise Software, Software. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the various public portfolio startups of the fund, we may underline Facebook, Palantir Technologies, Stemcentrx
This organization was formed by Mike Harden, Stuart Peterson. We also calculated 5 valuable employees in our database.
The increased amount of exits for fund were in 2011. The fund is constantly included in 2-6 investment rounds annually. Opposing the other organizations, this Artis Ventures (AV) works on 1 percentage points less the average amount of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from Artis Ventures (AV) the average startup value is more than 1 billion dollars. Speaking about the real fund results, this VC is 16 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2014. Despite it in 2019 the fund had an activity.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Artis Ventures (AV), startups are often financed by Norwest Venture Partners, Morgenthaler Ventures, Greylock Partners. The meaningful sponsors for the fund in investment in the same round are Founders Fund, Abstract Ventures, Oakhouse Partners. In the next rounds fund is usually obtained by Founders Fund, Morgenthaler Ventures, Worldview Technology Partners.
Related Funds
Funds with similar focus
Discover 4 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Second Front Systems | $70M | 13 Sep 2024 | Arlington, Virginia, United States | ||
Luminate Medical | $15M | 14 May 2024 | Galway, Galway, Ireland | ||
Rad AI | $50M | 07 May 2024 | Berkeley, California, United States | ||
OverT Bio | $16M | 06 May 2024 | New York, New York, United States | ||
Power Life Science | $11M | 22 Dec 2023 | San Francisco, California, United States | ||
Unnatural Products | $32M | 19 Dec 2023 | California, United States | ||
Ozlo Sleep | $10M | 03 Aug 2023 | Northborough, Massachusetts, United States | ||
Affect Therapeutics | $16M | 12 Jul 2023 | New York, New York, United States | ||
Range Biotechnologies | $5M | 12 Jun 2023 | San Carlos, California, United States |
– ViaCyte, a San Diego CA-based regenerative medicine company, raised $45M in Series D funding.
– The round, which brought total Series D to more than $115m, includes participation from existing investors Bain Capital Life Sciences, TPG Capital, RA Capital Management, Sanderling Ventures, Adage Capital Partners, Invus Group, Asymmetry Ventures, and Artis Ventures.
– The company intends to use the funds to advance its portfolio of stem cell-derived therapies designed to provide a functional cure for patients with type 1 diabetes.
– Transparent Health Marketplace, Inc. (THM) announced it has completed an oversubscribed $30m Series C Preferred equity funding round led by ARTIS Ventures.
– The latest funding brings THM’s total equity raised to $57.4m.
– THM operates the first marketplace of its kind to connect payors and providers of healthcare services within an open platform featuring market-driven pricing.
– The company has combined the power of the market with digital innovation to automate complex business processes and accelerate access to care for the healthcare and insurance industries.
– By integrating data and utilizing intelligent algorithms, THM’s platform is affording all stakeholders entry to a system that is transparent, intuitive, and beneficial.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Second Front Systems | $70M | 13 Sep 2024 | Arlington, Virginia, United States | ||
Luminate Medical | $15M | 14 May 2024 | Galway, Galway, Ireland | ||
Rad AI | $50M | 07 May 2024 | Berkeley, California, United States | ||
OverT Bio | $16M | 06 May 2024 | New York, New York, United States | ||
Power Life Science | $11M | 22 Dec 2023 | San Francisco, California, United States | ||
Unnatural Products | $32M | 19 Dec 2023 | California, United States | ||
Ozlo Sleep | $10M | 03 Aug 2023 | Northborough, Massachusetts, United States | ||
Affect Therapeutics | $16M | 12 Jul 2023 | New York, New York, United States | ||
Range Biotechnologies | $5M | 12 Jun 2023 | San Carlos, California, United States |
